Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004

APMIS

Volumn 115, Issue 4, 2007, Pages 299-310

  Advani, Abdolreza ^a,b   Donnelly, Declan ^a   Gustafsson, Lennart ^a   Hallander, Hans O ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Acellular pertussis vaccines; Bordetella pertussis; DNA fingerprinting; Genetic polymorphism; Incidence peaks; PFGE

Indexed keywords

BACTERIAL PROTEIN; FIMBRIA PROTEIN; FIMBRIA PROTEIN 3; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS TOXIN 1; PERTUSSIS TOXIN 3; PERTUSSIS VACCINE; TRACHEA COLONIZATION FACTOR; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ALLELE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM MUTANT; BORDETELLA PERTUSSIS; CHILD; CLONE; CONTROLLED STUDY; FIMBRIA; GENE EXPRESSION PROFILING; GENE SEQUENCE; HUMAN; NONHUMAN; PERTUSSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; STATISTICAL SIGNIFICANCE; SWEDEN; VACCINATION;

ALLELES; BORDETELLA PERTUSSIS; CHILD, PRESCHOOL; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INCIDENCE; MALE; PERTUSSIS VACCINE; POPULATION; SEROTYPING; SWEDEN; VACCINATION; VIRULENCE; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

EID: 34248563261     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2007.apm_556.x     Document Type: Article

References (33)

1. Ntezayabo B, De Serres G. Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J 2003 22 : 22 7.
2. McIntyre P, Gidding H, Gilmour R, Lawrence G, Hull B, Horby P, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. Commun Dis Intell 2002 Suppl i-xi : 1 111.
3. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005 24 : 761 5.
4. de Melker HE, Conyn-van Spaendonck MA, Rumke HC, van Wijngaarden JK, Mooi FR, Schellekens JF. Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis 1997 3 : 175 8.
5. Lee YS, Yang CY, Lu CH, Tseng YH. Molecular epidemiology of Bordetella pertussis isolated in Taiwan, 1992-1997. Microbiol Immunol 2003 47 : 903 9.
6. Cassiday P, Sanden G, Heuvelman K, Mooi F, Bisgard KM, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis 2000 182 : 1402 8.
7. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 1998 66 : 670 5.
8. Mooi FR, He Q, van Oirschot H, Mertsola J. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun 1999 67 : 3133 4.
9. Gzyl A, Augustynowicz E, van Loo I, Slusarczyk J. Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine 2001 20 : 299 303.
10. Fry NK, Neal S, Harrison TG, Miller E, Matthews R, George RC. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun 2001 69 : 5520 8.
11. Packard ER, Parton R, Coote JG, Fry NK. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol 2004 53 : 355 65.
12. Peppler MS, Kuny S, Nevesinjac A, Rogers C, de Moissac YR, Knowles K, et al. Strain variation among Bordetella pertussis isolates from Quebec and Alberta provinces of Canada from 1985 to 1994. J Clin Microbiol 2003 41 : 3344 7.
13. Weber C, Boursaux-Eude C, Coralie G, Caro V, Guiso N. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol 2001 39 : 4396 403.
14. Kodama A, Kamachi K, Horiuchi Y, Konda T, Arakawa Y. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol 2004 42 : 5453 7.
15. Byrne S, Slack AT. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003. BMC Infect Dis 2006 6 : 53.
16. Hallander HO, Advani A, Donnelly D, Gustafsson L, Carlsson RM. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J Clin Microbiol 2005 43 : 2856 65.
17. Advani A, Donnelly D, Hallander H. Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J Clin Microbiol 2004 42 : 2890 7.
18. Bisgard KM, Christie CD, Reising SF, Sanden GN, Cassiday PK, Gomersall C, et al. Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989-1996. J Infect Dis 2001 183 : 1360 7.
19. Hardwick TH, Cassiday P, Weyant RS, Bisgard KM, Sanden GN. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg Infect Dis 2002 8 : 44 9.
20. Syedabubakar SN, Matthews RC, Preston NW, Owen D, Hillier V. Application of pulsed field gel electrophoresis to the 1993 epidemic of whooping cough in the UK. Epidemiol Infect 1995 115 : 101 13.
21. van Amersfoorth SCM, Schouls LM, van der Heide HGJ, Advani A, Hallander HO, Bondeson K, et al. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol 2005 43 : 2837 43.
22. Olin P, Gustafsson L, Barreto L, Hessel L, Mast TC, Rie AV, et al. Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine 2003 21 : 2015 21.
23. Gustafsson L, Hallander HO, Olin P. SEVEN YEAR REPORT, Pertussis surveillance in Sweden, Progress Report October 1997 - September 2003. //www.smittskyddsinstitutet.se/upload/PDF-filer/seven-year-report.pdf.
24. Gustafsson L, Hessel L, Storsaeter J, Olin P. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics 2006 118 : 978 84.
25. Mooi FR, Hallander H, Wirsing von Konig CH, Hoet B, Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis 2000 19 : 174 81.
26. Caro V, Njamkepo E, Van Amersfoorth SCM, Mooi FR, Advani A, Hallander HO, et al. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect 2005 7 : 976 82.
27. van Loo IH, Heuvelman KJ, King AJ, Mooi FR. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol 2002 40 : 1994 2001.
28. Poynten M, McIntyre PB, Mooi FR, Heuvelman KJ, Gilbert GL. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol Infect 2004 132 : 185 93.
29. Finn TM, Stevens LA. Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant. Mol Microbiol 1995 16 : 625 34.
30. Tsang RS, Lau AK, Sill ML, Halperin SA, Van Caeseele P, Jamieson F, et al. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol 2004 42 : 5364 7.
31. Cherry JD. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr 1984 14 : 1 78.
32. Elomaa A, Advani A, Donnelly D, Antila M, Mertsola J, He Q, et al. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine 2006. Sep 20; [Epub ahead of print].
33. He Q, Makinen J, Berbers G, Mooi FR, Viljanen MK, Arvilommi H, et al. Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants? J Infect Dis 2003 187 : 1200 5.